Adicet Bio Statistics

Total Valuation

Adicet Bio has a market cap or net worth of $87.89 million. The enterprise value is -$35.80 million.

Market Cap	87.89M
Enterprise Value	-35.80M

Important Dates

The next estimated earnings date is Thursday, August 6, 2026, before market open.

Earnings Date	Aug 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Adicet Bio has 10.50 million shares outstanding. The number of shares has increased by 43.59% in one year.

Current Share Class	9.35M
Shares Outstanding	10.50M
Shares Change (YoY)	+43.59%
Shares Change (QoQ)	+3.64%
Owned by Insiders (%)	0.80%
Owned by Institutions (%)	37.53%
Float	7.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.64
P/TBV Ratio	0.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.65, with a Debt / Equity ratio of 0.10.

Current Ratio	7.65
Quick Ratio	7.54
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,928.80

Financial Efficiency

Return on equity (ROE) is -72.19% and return on invested capital (ROIC) is -42.89%.

Return on Equity (ROE)	-72.19%
Return on Assets (ROA)	-39.44%
Return on Invested Capital (ROIC)	-42.89%
Return on Capital Employed (ROCE)	-75.32%
Weighted Average Cost of Capital (WACC)	11.26%
Revenue Per Employee	n/a
Profits Per Employee	-$1.07M
Employee Count	102
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.50% in the last 52 weeks. The beta is 1.59, so Adicet Bio's price volatility has been higher than the market average.

Beta (5Y)	1.59
52-Week Price Change	-20.50%
50-Day Moving Average	8.06
200-Day Moving Average	9.16
Relative Strength Index (RSI)	55.33
Average Volume (20 Days)	88,386

Short Selling Information

The latest short interest is 517,922, so 4.93% of the outstanding shares have been sold short.

Short Interest	517,922
Short Previous Month	587,837
Short % of Shares Out	4.93%
Short % of Float	6.97%
Short Ratio (days to cover)	4.68

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-113.80M
Pretax Income	-108.83M
Net Income	-108.83M
EBITDA	-107.76M
EBIT	-113.80M
Earnings Per Share (EPS)	-$13.35

Full Income Statement

Balance Sheet

The company has $137.59 million in cash and $13.90 million in debt, giving a net cash position of $123.69 million or $11.78 per share.

Cash & Cash Equivalents	137.59M
Total Debt	13.90M
Net Cash	123.69M
Net Cash Per Share	$11.78
Equity (Book Value)	140.07M
Book Value Per Share	13.03
Working Capital	121.77M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$91.34 million and capital expenditures -$283,000, giving a free cash flow of -$91.62 million.

Operating Cash Flow	-91.34M
Capital Expenditures	-283,000
Depreciation & Amortization	6.04M
Net Borrowing	-150,000
Free Cash Flow	-91.62M
FCF Per Share	-$8.73

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Adicet Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.59%
Shareholder Yield	-43.59%
Earnings Yield	-123.82%
FCF Yield	-104.24%

Analyst Forecast

The average price target for Adicet Bio is $34.83, which is 316.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$34.83
Price Target Difference	316.13%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 30, 2025. It was a reverse split with a ratio of 1:16.

Last Split Date	Dec 30, 2025
Split Type	Reverse
Split Ratio	1:16

Scores

Altman Z-Score	n/a
Piotroski F-Score	1